NCT06997068
- Conditions
- Carcinoma, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Cancer, +34 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Stage IVC Hypopharyngeal Carcinoma AJCC v8
Explore clinical trials studying Stage IVC Hypopharyngeal Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Stage IVC Hypopharyngeal Carcinoma AJCC v8 trial results
NCT04541355
- Conditions
- Carcinoma, Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +45 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Active, Not Recruiting
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT04862650
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States